The Latest Updates from ReSPECT Clinical Trials

Susan G. Komen: LM

Thank you to @SusanGKomen for adding "Leptomeningeal Metastasis" to your Breast Cancer Glossary patient resource! 🎗️ "Leptomeningeal Metastasis: Cancer that spreads from the original tumor to the meninges (the thin layers of tissue that cover and protect the brain and...

read more

CSF-01 Announcement

BREAKING NEWS: Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic > Plus’ CSF-01 cancer cell enumeration test is a sensitive and specific diagnostic test for the presence of adenocarcinoma and...

read more

IR Events

Want to hear the latest milestones from our team? We have replays of all our events and earnings calls on our website at IR.PlusTherapeutics.com/Events. Questions about any of the recorded events? Contact us at https://ir.plustherapeutics.com/resources/contact-ir...

read more

Head for the Cure Austin

Join some of the Plus Therapeutics team at the @HeadfortheCure 5K in Austin, TX on March 24! They will be out supporting the local community, cancer research, and "Defeating Brain Cancer Step by Step." We hope to see you there 🏃🏃‍♂️🏃‍♀️ Event information:...

read more

Corporate Presentation

AVAILABLE NOW: The new Plus Therapeutics corporate presentation, which reflects our current data, milestones, and pipeline, is on our website. View it directly here: https://bit.ly/3PiHClj Questions about anything or interested in learning more? Visit our website at...

read more

LM Cohort 5 Completion

BREAKING NEWS! We have completed dosing in Cohort 5 of our ongoing ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases, with a total of 18 patients have been dosed in the trial to date. The trial is STILL ENROLLING and accepting new...

read more

“Glioblastoma AKA GBM” Sponsorship

We are thrilled to announce our sponsorship with @glioblastomaresearch this upcoming season on their "Glioblastoma AKA GBM" podcast! 🧠 We appreciate their goal of raising awareness and funds for new global, cutting-edge research to find a cure for Glioblastoma and...

read more

Miami Breast Conference

Some of our clinical team will be attending the #MiamiBreast Cancer Conference this week, as it relates to our Leptomeningeal Metastases clinical trial for Metastatic Breast Cancer patients. If you are interested in connecting with the team there, send us a DM. See...

read more

Rare Disease Day 2024

Today on leap day, the rarest day of the year, we celebrate Rare Disease Day along with the NIH and other organizations. Plus Therapeutics is dedicated to developing innovative, targeted radiotherapeutics for adult & pediatric patients with rare &...

read more

Head for the Cure Sponsorship

We are excited to announce our national partnership with @HeadfortheCure! 🎉 Their goals of building awareness, raising funds, and igniting hope for the brain tumor community strongly align with our mission. Look out for more information regarding our upcoming...

read more

ABTA Collaboration

We love working with the @the_ABTA and are so excited about our upcoming collaborative projects with them. More to come‼️ ABTA Brain Tumor Resources: https://www.abta.org/about-brain-tumors/ ReSPECT-GBM Clinical Trial Patient Resource:...

read more

UMMC Nuclear Medicine Conference

We will see you at the Nuclear Medicine Conference at the University of Mississippi Medical Center this weekend! Come grab some information on our ReSPECT-GBM and ReSPECT-LM clinical trials https://www.respect-trials.com/ #NuclearMedicine #ClinicalTrials #Oncology...

read more

LM Patient Study Guide

⭐ We have a NEW Patient Guide for our Leptomeningeal Metastases trial available NOW on our website at ReSPECT-Trials.com! Please share this resource with caregivers and patients that may be interested in enrolling for our Phase 1 ReSPECT-LM clinical trial. #BrainMets...

read more

What is a Nanoliposome?

Nanoliposomes are a safe and reliable way to encapsulate, deliver and retain radiation within a specific injection site. We design nanoliposomes at 100 nanometers, the ideal size to facilitate accumulation and retention at the site of injection. As nanoliposomes are...

read more

Pediatric Brain Cancer Resources

We value patient education and want to provide some resources for Pediatric Brain Cancer caregivers 💛 Ependymoma Cancer Guide: https://www.respect-trials.com/patient-guide-ependymoma/ Pediatric High-Grade Glioma Cancer Guide:...

read more